A new study concludes that state marijuana legalization laws are not associated with increases in “problematic” cannabis consumption or with more impulsive behaviors. “The results indicated...
A bipartisan group of U.S. representatives is seeking answers about why the federal government is seemingly favoring foreign marijuana suppliers while stalling the approval of additional...
A bill that would have allowed California marijuana merchants to give product away free of charge to low-income people was one of a slew of drug...
Last week’s decision by the U.S. Drug Enforcement Administration (DEA) to place a marijuana-derived drug in the least restrictive category under federal law was largely based...
Missouri is proving to be one of the most consequential battlegrounds in Democrats’ fight to regain control of the U.S. Senate, with polls showing Democratic incumbent...
New studies on marijuana are churned out nearly every day, with most of them focusing on novel findings about the plant’s therapeutic potential and the implications...
The fate of federal marijuana policy reform is squarely in the hands of President Donald Trump, no matter what happens in November’s midterm elections, House Minority...
The number two U.S. House Democrat supports making medical marijuana available and says ending criminalization more broadly “probably makes sense,” but acknowledges that party leaders have...
The Drug Enforcement Administration (DEA) placed a marijuana-derived drug in Schedule V of the Controlled Substances Act on Thursday. The medication, Epidiolex, contains purified cannabidiol (CBD),...
The powerful House Rules Committee has blocked lawmakers from voting on another marijuana-related measure. This time, the panel prevented an amendment to allow cannabis growers, sellers...